Rare Disease Trial, Recruiting (NCT06285500)

Rare Disease Trial, Recruiting NCT06285500 Sponsor: University Health Network, Toronto Condition: Rare Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06285500 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Rare Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Your tumor's genetic information will be reviewed by a specialist medical team to decide if a personalised treatment option may be suitable for you (confirm with trial site)
Eligibility is assessed on a case-by-case basis, based on your individual medical history and the results of your tumor's genetic testing (confirm with trial site)

Who may not be able to join:

There are no fixed exclusion criteria listed, but your personal medical history will be taken into account when the specialist team reviews your case (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Amit Oza, Dr., University Health Network, Toronto

Phone: 416 946 4450

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06285500

Sponsor: University Health Network, Toronto

Phase: Not Applicable

Status: Recruiting

Condition: Rare Disease

Trial contact: 416 946 4450

More information: https://clinicaltrials.gov/study/NCT06285500

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Your tumor's genetic information will be reviewed by a specialist medical team to decide if a personalised treatment option may be suitable for you (confirm with trial site)
Eligibility is assessed on a case-by-case basis, based on your individual medical history and the results of your tumor's genetic testing (confirm with trial site)

Who may not be able to join:

There are no fixed exclusion criteria listed, but your personal medical history will be taken into account when the specialist team reviews your case (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Health Network, Toronto

Registry

ClinicalTrials.gov

Start date

1 February 2024

Est. completion

1 February 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Overall response rate for the overall cohorts and the number of patients accessing precision targeted therapy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov